Role PKA and p38 MAPK on ROS production in neutrophil age-related: Lack of IL-10 effect in older subjects

• Published in: Mechanisms of ageing and development 2009-09, Vol.130 (9), p.588-591
• Main Authors: Chaves, Míriam Martins, Costa, Daniela Caldeira, de Oliveira, Bárbara Fonseca, Rocha, Marcella Israel, Nogueira-Machado, José Augusto
• Format: Article
• Language: English
• Subjects: Age; Aged; Akt/PKB; Biological and medical sciences; Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors; Cyclic AMP-Dependent Protein Kinases - metabolism; Development. Metamorphosis. Moult. Ageing; Enzyme Inhibitors - pharmacology; Female; Fundamental and applied biological sciences. Psychology; Humans; Imidazoles - pharmacology; Interleukin-10 - pharmacology; Isoquinolines - pharmacology; Male; Neutrophil; Neutrophils - drug effects; Neutrophils - enzymology; Neutrophils - metabolism; p38 MAPK; p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors; p38 Mitogen-Activated Protein Kinases - metabolism; PKA; Protein Kinase Inhibitors - pharmacology; Reactive Oxygen Species - antagonists & inhibitors; Reactive Oxygen Species - metabolism; Sulfonamides - pharmacology; Vertebrates: anatomy and physiology, studies on body, several organs or systems
• ISSN: 0047-6374; 1872-6216
• DOI: 10.1016/j.mad.2009.07.001

There is a large increase in the number of elderly people in modern societies. This demographic phenomenon has been paralleled by an epidemic of chronic diseases and inflammatory processes usually associated with advanced age. We studied the role of protein kinase A (PKA), protein kinase B (Akt/PKB) and p38 mitogen-activated protein kinase (p38 MAPK) signaling pathways in ROS produced by neutrophils induced by pro-interferon-gamma (IFN-γ) or anti-inflammatory interleukin 10 (IL-10) cytokines age-related. The ROS generation was studied in healthy subjects in age ranging from 20 to 80 years old divided in five age groups: (20–39), (40–49), (50–59), (60–69) and (70–80) years old. ROS production was quantified in a luminol-dependent chemiluminescence assay and the results were expressed as relative light units/min). ROS production in human neutrophil was activated by IFN-γ in all the groups studied. This activation was down-regulated by IL-10. The inhibitory effect of IL-10 on 20–49 years old group was reversed by the pre-treatment with H89 (PKA inhibitor) but not with PD169316 (p38 MAPK inhibitor). This differential effect of IL-10 associated with age was not observed with the neutrophil pre-treatment with Akt/PKB or NADPH-oxidase inhibitor (DPI). Lack of IL-10 effect on ROS production was observed in older subjects (50–80 years old). The effect of IL-10 showed a significant inhibition of ROS production similar to those got with PD169316 alone as compared to that of p38 MAPK. The results suggest that inhibitory effect of the ROS production mediated by IL-10 depends on PKA for the younger and the lack effect on the elderly is p38 MAPK dependent.